1. Home
  2. DNTH vs PEO Comparison

DNTH vs PEO Comparison

Compare DNTH & PEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • PEO
  • Stock Information
  • Founded
  • DNTH 2015
  • PEO 1929
  • Country
  • DNTH United States
  • PEO United States
  • Employees
  • DNTH N/A
  • PEO N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • PEO Finance/Investors Services
  • Sector
  • DNTH Health Care
  • PEO Finance
  • Exchange
  • DNTH Nasdaq
  • PEO Nasdaq
  • Market Cap
  • DNTH 724.8M
  • PEO 596.4M
  • IPO Year
  • DNTH N/A
  • PEO N/A
  • Fundamental
  • Price
  • DNTH $18.14
  • PEO $22.87
  • Analyst Decision
  • DNTH Strong Buy
  • PEO
  • Analyst Count
  • DNTH 8
  • PEO 0
  • Target Price
  • DNTH $54.33
  • PEO N/A
  • AVG Volume (30 Days)
  • DNTH 362.0K
  • PEO 35.4K
  • Earning Date
  • DNTH 03-11-2025
  • PEO 01-01-0001
  • Dividend Yield
  • DNTH N/A
  • PEO 5.93%
  • EPS Growth
  • DNTH N/A
  • PEO N/A
  • EPS
  • DNTH N/A
  • PEO N/A
  • Revenue
  • DNTH $6,235,000.00
  • PEO N/A
  • Revenue This Year
  • DNTH N/A
  • PEO N/A
  • Revenue Next Year
  • DNTH N/A
  • PEO N/A
  • P/E Ratio
  • DNTH N/A
  • PEO N/A
  • Revenue Growth
  • DNTH 120.63
  • PEO N/A
  • 52 Week Low
  • DNTH $17.50
  • PEO $19.22
  • 52 Week High
  • DNTH $32.27
  • PEO $23.80
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 36.91
  • PEO 58.74
  • Support Level
  • DNTH $17.50
  • PEO $22.41
  • Resistance Level
  • DNTH $20.45
  • PEO $23.20
  • Average True Range (ATR)
  • DNTH 1.67
  • PEO 0.34
  • MACD
  • DNTH -0.22
  • PEO 0.08
  • Stochastic Oscillator
  • DNTH 10.44
  • PEO 81.67

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About PEO Adams Natural Resources Fund Inc.

Adams Natural Resources Fund Inc is a closed-end equity investment company specializing in energy and other natural resources stocks. The investment objectives of the fund are the preservation of capital, the attainment of reasonable income from investments, and an opportunity for capital appreciation. Its portfolio of investments comprises of different sector investments such as in the energy sector and basic materials.

Share on Social Networks: